🇨🇦 Lorlatinib with chemotherapy 2 in Canada

Lorlatinib with chemotherapy 2 (lorlatinib-with-chemotherapy-2) regulatory status in Canada.

Marketing authorisation

Lorlatinib with chemotherapy 2 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Lorlatinib with chemotherapy 2 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Lorlatinib with chemotherapy 2 in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.